Literature DB >> 32672280

Molecules derived from the extremes of life: a decade later.

Zoe E Wilson1, Margaret A Brimble.   

Abstract

Covering: Early 2008 until the end of 2019Microorganisms which survive (extreme-tolerant) or even prefer (extremophilic) living at the limits of pH, temperature, salinity and pressure found on earth have proven to be a rich source of novel structures. In this update we summarise the wide variety of new molecules which have been isolated from extremophilic and extreme-tolerant microorganisms since our original 2009 review, highlighting the range of bioactivities these molecules have been reported to possess.

Year:  2020        PMID: 32672280     DOI: 10.1039/d0np00021c

Source DB:  PubMed          Journal:  Nat Prod Rep        ISSN: 0265-0568            Impact factor:   13.423


  4 in total

1.  Cylindromicin from Arctic-Derived Fungus Tolypocladium sp. SCSIO 40433.

Authors:  Imran Khan; Jing Peng; Zhuangjie Fang; Wei Liu; Wenjun Zhang; Qingbo Zhang; Liang Ma; Guangtao Zhang; Changsheng Zhang; Haibo Zhang
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

2.  Antimicrobial and Antioxidant Polyketides from a Deep-Sea-Derived Fungus Aspergillus versicolor SH0105.

Authors:  Lu-Jia Yang; Xiao-Yue Peng; Ya-Hui Zhang; Zhi-Qing Liu; Xin Li; Yu-Cheng Gu; Chang-Lun Shao; Zhuang Han; Chang-Yun Wang
Journal:  Mar Drugs       Date:  2020-12-11       Impact factor: 5.118

Review 3.  Beyond Soil-Dwelling Actinobacteria: Fantastic Antibiotics and Where to Find Them.

Authors:  Javier Santos-Aberturas; Natalia M Vior
Journal:  Antibiotics (Basel)       Date:  2022-02-02

4.  Dermacozine N, the First Natural Linear Pentacyclic Oxazinophenazine with UV-Vis Absorption Maxima in the Near Infrared Region, along with Dermacozines O and P Isolated from the Mariana Trench Sediment Strain Dermacoccus abyssi MT 1.1T.

Authors:  Bertalan Juhasz; Dawrin Pech-Puch; Jioji N Tabudravu; Bastien Cautain; Fernando Reyes; Carlos Jiménez; Kwaku Kyeremeh; Marcel Jaspars
Journal:  Mar Drugs       Date:  2021-06-03       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.